Skip to main content

What Baxter's Quarter ended Sep 30, 2026 10-Q says: 5 signals

Baxter filed its latest 10-Q with the SEC on Oct 29, 2026. It discusses compliance burden, digital transformation and product liability.

Public (BAX)Medical Equipment Manufacturing10,000+ employeesbaxter.comLinkedIn

Get Baxter's live signals in Claude or ChatGPT, or by API

AskWhat changed at Baxter this week? Use Autobound signals for baxter.com.
Filed
Oct 29, 2026
Period
Quarter ended Sep 30, 2026
Filings
3
Signals
17

Source: Autobound Signal API · 62 signals tracked for Baxter · updated

10-Q · latest 10

What Baxter's 10-Q filings say

  1. 10-Q · Quarter ended Sep 30, 2026

    Filed · 5 signals

    SEC EDGAR
  2. 10-Q · Quarter ended Jun 30, 2026

    Filed · 6 signals

    SEC EDGAR

Earlier 10-Q filings

  • 10-Q · Quarter ended Mar 31, 2026Filed · 6 signalsSEC EDGAR

Showing 10 of 17 filing signals. The Signal API returns all of them.

Get them with one API call

Earnings calls

Baxter earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call dateWhat the company said
FDA warning letter prompts Round Lake facility manufacturing repositioningThe company received an FDA warning letter following an inspection at its Round Lake, Illinois facility, creating operational disruption and compliance requirements. In response, management is discontinuing its cephalosporin product line to simplify site operations and address inspection observations. This presents opportunities for regulatory compliance, quality management, and cleanroom...
New Chief Financial Officer appointed to lead business turnaroundJohn Rogers joined as Executive Vice President and Chief Financial Officer on October 1, bringing operational turnaround experience. Leadership transitions at the CFO level often trigger comprehensive vendor reviews, budget audits, and adjustments to capital allocation. Rogers emphasized plans to evaluate capital allocation policies, cost structures, and operational efficiencies.
Cephalosporin production discontinued incurring $39M restructuring costManagement decided to terminate cephalosporin manufacturing at its Round Lake facility, incurring $39 million in restructuring costs in Q3. The discontinued product lines represent $50 million in revenue and $30 million in operating income in 2026. This operational restructuring streamlines the facility exclusively for non-cephalosporin production while leaving customers supported under...
Injectables growth impacted by contract manufacturing supply disruptionsThird-quarter injectables performance was negatively affected by supply challenges originating from an outsourced contract manufacturer. While management noted sequential improvement, the issue caused headwind earlier in the year and required dedicated intervention to mitigate. Solutions around contract manufacturing oversight, supplier risk management, and track-and-trace monitoring are...
Fragmented IT application landscape targets standardization and rationalizationIncoming CFO John Rogers identified embedded complexity across IT and finance functions, specifically pointing out an excessive number of disparate applications. Management intends to simplify and standardize non-standard operational processes and application sprawl over the next 1 to 3 years. Enterprise software vendors offering ERP consolidation, IT service management, and application...
Over 700 continuous improvement initiatives deployed across operationsThe company has integrated its continuous improvement operating system, completing over 700 initiatives year-to-date with 200 in flight and 350 planned. Operational wins include cutting blood pressure cuff cycle times by over 10% and reducing alternate shipment back orders by over 50%. This ongoing push creates opportunities for industrial engineering, lean manufacturing, and workflow...

Signal API · MCP

Track Baxter with the Signal API

One POST /v1/companies/enrich call with baxter.com returns Baxter 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"baxter.com","signal_types":["sec-10q"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.

Talk to sales

Same industry

Questions about Baxter 10-Q

When did Baxter file its latest 10-Q?
Baxter filed its latest 10-Q (Quarter ended Sep 30, 2026) on Oct 29, 2026. The one before it was filed on Jul 30, 2026.
What did Baxter disclose in its latest 10-Q?
From the filing dated Oct 29, 2026: Baxter halted Novum LVP distribution following FDA Class I recall classification
What did Baxter say on its recent earnings calls?
Q3 FY2026: FDA warning letter prompts Round Lake facility manufacturing repositioning (dated Oct 29, 2026).
Where can I read Baxter's 10-Q filing?
The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/10456/000162828026068278/bax-20260930.htm. This page summarizes what the filing says and links to it.

Page updated , the date of the newest row on this page.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of .

How this data is built →Get it from the Signal API →